Shareholder plans Rule 144 sale of 1,779 TVTX shares

TVTX shareholder Jula Inrig has filed a Form 144 to sell 1,779 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 57299.10.

Rhea-AI Filing Summary

TVTX shareholder Jula Inrig has filed a Form 144 to sell 1,779 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of 57299.10. The proposed sale is expected around 02/04/2026 on the NASDAQ, where 89,472,327 common shares are outstanding.

The shares to be sold were acquired as restricted stock from the issuer on 01/31/2026. In the past three months, Jula Inrig has already completed several sales of TVTX common stock, including 15,000 shares for gross proceeds of 630004.50 and other smaller transactions disclosed in the filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the TVTX Form 144 filing disclose about planned share sales?

The Form 144 filing discloses that shareholder Jula Inrig plans to sell 1,779 TVTX common shares with an aggregate market value of 57299.10. The planned sale will occur on the NASDAQ around 02/04/2026 through Morgan Stanley Smith Barney LLC.

How many TVTX shares did Jula Inrig sell in recent transactions?

Recent disclosed sales include 15,000 TVTX common shares on 12/24/2025 for 630004.50, 6,956 shares on 02/03/2026 for 223429.38, 445 shares on 01/06/2026, and 2,031 shares on 01/05/2026, all with stated gross proceeds.

When and how were the TVTX shares in the new Form 144 acquired?

The 1,779 TVTX common shares covered by the new Form 144 were acquired on 01/31/2026 as restricted stock from the issuer. The filing notes the nature of the acquisition as “Restricted Stock” and lists the issuer as the source of the securities.

What trading venue and broker are involved in the planned TVTX share sale?

The planned sale of 1,779 TVTX common shares is to be executed on the NASDAQ. The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as disclosed in the filing.

How many TVTX common shares are outstanding according to this filing?

The filing reports that 89,472,327 TVTX common shares are outstanding. This figure provides context for the relative size of the planned 1,779-share sale disclosed under Rule 144, but it is a baseline ownership number rather than an amount being sold.

Does the TVTX Form 144 mention any special payment terms for the shares acquired?

For the 1,779 TVTX restricted shares acquired on 01/31/2026, the Form 144 lists the nature of payment as “Not Applicable.” The form also explains that any non-cash or installment consideration would need to be described, but no such arrangements are indicated here.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/04/2026 - 04:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001902368
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	JULA INRIG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1779	57299.10	89472327	02/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2026	Restricted Stock	ISSUER			1779	01/31/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JULA INRIG 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	12/24/2025	15000	630004.50
JULA INRIG 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/03/2026	6956	223429.38
JULA INRIG 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	01/06/2026	445	16798.75
JULA INRIG 3611 Valley Centre Drive Suite 300 San Diego CA 92130	common	01/05/2026	2031	81605.58

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jula Inrig
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)